Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Got back in at 1.45 after a quick sell at 1.50 (just saw a opportunity to be a day trader).
Should be good tomorrow
I got into the "pot" stocks on friday and it worked out pretty well lol
Looks thin... doing some DD and I may enter
AXU.. Yeah, I waited until those were gone but got in heavy at 1.05ish and now have an avg of 1.14.
You can't deny when a company has assets, similar to my other STV play
6:04AM Vical Phase 3 trial of Allovectin fails to meet efficacy endpoints; co focusing resources on infectious disease vaccine programs (VICL) 3.58 : Co announced top-line results from a Phase 3 trial of Allovectin (velimogene aliplasmid), an investigational intratumoral cancer immunotherapy, in patients with metastatic melanoma. The 390-subject trial failed to demonstrate a statistically significant improvement vs. first-line chemotherapy for either the primary endpoint of objective response rate at 24 weeks or more after randomization or the secondary endpoint of overall survival. Trial data will be further analyzed and detailed results will be submitted for publication. "Based on this outcome, we are terminating the Allovectin program and focusing our resources on our infectious disease vaccine programs... In the coming weeks, we will make the necessary changes to focus resources on our infectious disease vaccine programs and reduce expenses to conserve cash."
The co reported cash and investments of $70 mln at June 30, 2013, which it believes is adequate for its anticipated needs at least through the end of 2014. Vical has multiple independent and collaborative infectious disease vaccine programs:
Astellas Pharma (ALPMY) initiated a multinational 500-patient Phase 3 trial of ASP0113, Vical's investigational therapeutic vaccine designed to control cytomegalovirus in transplant recipients, for hematopoietic cell transplant recipients in June and expects to initiate a Phase 2 trial of ASP0113 for solid organ transplant recipients later this year.
The co is planning to initiate a Phase 1/2 clinical trial of its Vaxfectin-formulated therapeutic vaccine against herpes simplex virus type 2 before the end of 2013. The co's Vaxfectin-formulated CyMVectin prophylactic vaccine, designed to prevent CMV infection before and during pregnancy, has completed preclinical development and has an allowed investigational new drug application. Co is seeking a partner for further development.
Vical has licensed its proprietary Vaxfectin adjuvant to Bristol-Myers Squibb (BMY) for use in the production of antibodies, and to Cyvax, a privately held vaccine development co, for use in malaria vaccines. The co is pursuing additional licensing opportunities for Vaxfectin.
Someone bought over 17,000 shares at the 1.45 break lol
AXU at the HOD again pushing at the resistance..
You have to disclose over 5% ownership... If they offer to buy out the company it can be used against them in court. Activison's only option is to go to court and hope they can win on some technicality.
AXU... I'm doing pretty good with that one today! I'm holding through earnings
ONTY had a 95k buy at the EOD (also HOD)... Which is about 1/5th of the daily volume.
Interesting...
So the judge not only screwed Worlds once by delaying the markman she even denied their request to have the MSJ and markman on the same day in October. Why couldn't the MSJ be on Aug 22-23? Does she want that day off to go golfing with Obama?
Very unfair.
CLSN Filled lol
AXU... My bad
STV... You guys should do your own DD on this one. It is a stock that has a market cap of 97mil brings in a consistent 18-20mil a year net income. It has so much cash that it pays out huge dividends because they don't have other investments.
Problem is that it is a chinese stock that offers unaudited earnings (lot of scams out there). But I am reassured that the earnings are good if they pay 2.3$ dividends!
CLSN... I'm going to get into this if it hits 1.18... They put out pretty good news just needs a catalyst. Hopefully more info on the partnerships will be enough to recharge it.
You saw the premarket results yesterday and wanted in, can't blame yourself for trying to get in early
Earnings now going to be released Aug 14... this could be a very big catalyst if they reported earnings (but I doubt they will) but I believe the operating cost have gone down substantially. I want to see a big increase in silver inventory personally.
CLSN hitting a brick wall at 1.37
SA article http://seekingalpha.com/article/1618392-celsion-reaffirms-hope-for-thermodox-in-q2-call?source=yahoo
This will volume will translate into the smaller miners soon, IMO
Hopefully AXU!
Well in for the past 10 years it has been 64:1 but many people believe silvers intrinsic value is 16:1. I think silvers downfall is it is easier to produce (although it is more heavily consumed) and has lost some credibility as a form of currency
http://www.kitco.com/Gold_Silver_Ratio_Charts/gold-silver-ratio-charts.html
gold/silver ratio balanced back to 64:1 it was at 67:1 for a while there.
No volume though... EGO is getting solid volume
AXU up but no volume on any of the miner stocks... People must be board of them or waiting for earning news
Was this targeted at me? They have a possible 150mil shares to public offer, and if they do not have the cash to pay for operations waiting for trial, how else are they going to get it?
Sorry for being so emotional... lol
P.S.
I still believe in the patents and am continuing to buy at these levels...
In at .231
Anybody thinking now the stock have to be more diluted to keep sufficient funds?
Glad I got into AXU yesterday at 1.05! Should shoot up with silver in the 20$ range
35 U.S.C. 102 B that was acted on has an effective date on march 17 2013. The motions were filed prior to that and the patents obviously were filled way before that. A motion for summary should be quick based on this.
What was the share price sold at for that 300K? If the pps was half than you can see the difference.
This took place on dec 5 when the share price was .15. So if this is where the selling is coming from then we are about half way there
Well the good news is that there is a huge amount of resistance at .265 which is right about at my .26 avg
Wedbush raises price target for Oncothyreon $ONTY to USD 5.00... Thank god I didn't sell my entire position
OCZ seems to be holding at the 1.89 level
My portfolio looks like a movie theater showing batman with James Eagan Holmes
STV holding strong at 1.65 from 1.48... earnings out aug 20th and they should be good! The only problem with this company is they give out 2.3$ dividends and it crushes the pps
Link?
ONTY sold half of my positions yesterday at 1.84 for a loss but still holding for the Aug 13 conference they will be presenting at. They are teaming up with a bunch of people to get drugs produced.
Well then if there isn't that much risk than there must not be that much reward if you follow the idiom... (lol just being a dick)
The greater the risk the greater the reward lol... I'll sit on the sidelines for this one though and cheer you guys on!
Why do you think this? OCZ isn't that attractive for a buyout (if that is the news you are thinking of)